Abstract
Background: The benefits of cannabis in symptom management among cancer survivors are widely acknowledged; however, patterns of cannabis use by cancer stage at diagnosis are unknown. Methods: Here, we examined the association between cancer stage at diagnosis and consideration of cannabis use since diagnosis. We analyzed cross-sectional survey data from 954 cancer survivors, weighted to be representative of a National Cancer Institute–Designated Comprehensive Cancer Center’s patient population. We used survey-weighted multivariable logistic regression to examine the association between cancer stage at diagnosis (advanced [III/IV] versus non-advanced [I/II]) and consideration of cannabis use (yes versus no) since diagnosis. Results: Sixty percent of the population was diagnosed with non-advanced stages of cancer, and 42% had considered using cannabis since diagnosis. The odds of consideration of cannabis use were 63% higher (odds ratio = 1.63, 95% confidence interval = 1.06 to 2.49) among cancer survivors diagnosed at stages III/IV than among those diagnosed at stages I/II. Conclusion: Cancer stage may be a predictor of consideration of cannabis use after diagnosis.
Funding Information
  • NCI (P30 CA023100-34S3)
  • San Diego State University
  • University of California San Diego Cancer Partnership (U54 CA132384, U54 CA132379)
  • Moores Cancer Center
  • UC San Diego Health (P30 CA023100)
  • NCI (K01 CA234317)
  • University of California San Diego Cancer Center Partnership (U54 CA132384, U54 CA132379)
  • San Diego Alzheimer’s Disease Resource Center for Minority Aging Research (P30 AG059299)